In The News

2016

Innovations: Surfacer Inside-Out Access Catheter System

October 13, 2016

PUBLICATION: Endovascular Today Europe

A preview of today’s new products: Bluegrass Vascular Technologies, Inc. announced that it has received CE Mark approval and has launched a limited commercial sale of its Surfacer Inside-Out access catheter system in Europe. The Surfacer system is indicated for obtaining central venous access to facilitate catheter insertion into the venous system via a novel inside-out approach.

READ MORE

San Antonio firm creates innovative catheter system

September 23, 2016

Sept. 23, 2016

MEDIA: KLRN PBS – SciTech Now

SciTech Now, a PBS newsmagazine program, explores the innovative Surfacer Inside-Out Access Catheter System, created by Bluegrass Vascular Technologies. The video depicts the Surfacer System, which recently received CE Mark approved for use in the European Union market.

WATCH VIDEO

Bluegrass Vascular announces CE mark approval and successful commercial use of Surfacer Inside-Out access catheter system

August 31, 2016

August 31, 2016

Publication: Vascular News

Bluegrass Vascular Technologies has received CE mark approval and is launching limited commercial sale of its Surfacer Inside-Out access catheter system. The Surfacer system is indicated for obtaining central venous access to facilitate catheter insertion into the central venous system via a novel “Inside-Out” approach.

READ MORE

Bluegrass Vascular’s Surfacer Inside-Out Access Catheter System Approved in Europe

August 30, 2016

August 30, 2016

Publication: Endovascular Today

Bluegrass Vascular Technologies announced that it has received European CE Mark approval for its Surfacer Inside-Out access catheter system, which is indicated for obtaining central venous access to facilitate catheter insertion into the central venous system via an “inside-out” approach. The Surfacer system is available in limited markets, including the United Kingdom, Germany, Austria, Italy, and the Benelux countries.

READ MORE

Lifesaving European premier

April 23, 2016

PUBLICATION: Badische Zeitung

Article written and published in German. Under special compassionate use permission in Germany at the Ortenau Klinikum in Offenburg-Gengenbach, a 73-year-old female patient with end-stage renal disease and requiring dialysis to survive was referred to the Ortenau Klinikum for the novel Surfacer System procedure.

READ MORE

Bluegrass device moving closer to market

April 8, 2016

PUBLICATION: San Antonio Business Journal

San Antonio-based Bluegrass Vascular Technologies is making some significant headway outside the U.S. The biotech firm has moved closer to securing a CE Mark, regulatory approval that would allow Bluegrass Vascular to commercialize its initial medical device, the Surfacer Inside-Out Access Catheter System, in Europe.

READ MORE

SA biotech firm making critical progress in Europe with first medical device

March 30, 2016

PUBLICATION: San Antonio Business Journal

Bluegrass Vascular Technologies Inc. has taken a critical step toward commercialization of its initial medical device — the Surfacer Inside-Out Access Catheter System. Gabriele Niederauer, president and CEO of the private medical technology company, which is based in San Antonio and focused on vascular access technologies, said a European medical team has now successfully used its Surfacer System on a patient with life-threatening complications from end-stage renal disease.

READ MORE

2015

Ten Life Sciences Companies to Watch in Central Texas

August 5, 2015

PUBLICATION: Silicon Hills

Bluegrass Vascular Technologies – the San Antonio-based startup relocated from Lexington, Kentucky. It raised $4.5 million in Series A financing last year led by the Targeted Technology Fund of San Antonio. The company makes the Surfacer, a central venous access catheter system. Gabriele Niederauer joined the company in September of 2014 as its CEO and President.

READ MORE

San Antonio developing biotech executive talent

February 6, 2015

PUBLICATION: San Antonio Express News

Serial entrepreneurs are those who take on the risks of building a company good enough to be sold to an older, larger company and taking the proceeds to start another company. An example of such an executive in San Antonio’s health care and medical devices sector is Gabriele Niederauer, now CEO and president of Bluegrass Vascular Technologies Inc.

READ MORE

Forecast: Three San Antonio biomedical companies to watch in 2015

January 13, 2015

PUBLICATION: San Antonio Business Journal

Bluegrass Vascular Technologies is developing a special catheter system that enables physicians to gain venous access to a patient using a novel approach. The company moved from Kentucky to San Antonio last year after closing on $4.5 million in funding and then hired Dr. Gabriele Niederauer, a seasoned senior medical device executive, as its president and CEO.

READ MORE

2014

San Antonio biotech firm Bluegrass Vascular Technologies secures new leadership

September 2, 2014

PUBLICATION: San Antonio Business Journal

Bluegrass Vascular Technologies has been quite busy of late by closing on a new round of funding and hiring a new chief executive to lead the biotech company. In late July, I reported that the Kentucky-based medical technology company had closed on $4.5 million in new investor funding and was relocating to San Antonio.

READ MORE

Inside-Out Upper Body Venous Access: First in Human Experience with a Novel Approach Using the Surfacer System

March 1, 2014

PUBLICATION: Cath Lab Digest: Volume 22 – Issue 3, March 2014

Severe renal dysfunction and venous occlusive disease is a major cause of morbidity, mortality, and increased medical costs, especially within the dialysis population. The long-term risks of central venous access include occlusion, which can occur within days of catheter placement and is a common problem in patients requiring repeated access or semi-permanent access.

READ MORE

2013

Inside-Out Upper Body Venous Access. The first-in-human experience with a novel approach using the Surfacer inside-out access catheter system

June 1, 2013

PUBLICATION: Endovascular Today

Severe renal dysfunction and venous occlusive disease are major causes of morbidity, mortality, and increased medical costs, especially within the dialysis population. The long-term risks of central venous access include occlusion, which can occur within days of catheter placement and is a common problem in patients requiring repeated access or semipermanent access. Central venous occlusion can deprive patients of vital therapies such as hemodialysis, cardiac pacing, chemotherapy, and drug infusion.

READ MORE

2012

Bluegrass Vascular Technologies: Novel “inside-out” approach to central venous access

April 1, 2012

PUBLICATION: Start-Up Magazine

Although central venous catheters are commonly employed to lever long-term dialysis, nutrition and chemotherapy, nearly 10% of patients have an upper extremity venous occlusion that renders the vein impenetrable by standard access techniques.

READ MORE

In the right vein

March 2, 2012

PUBLICATION: BusinessLexington

When he was president of the University of Kentucky, Lee Todd strongly encouraged faculty members to take their original ideas to the next step and turn them into new businesses and jobs to better the commonwealth. One company to emerge from the minds of UK personnel was technology incubator Therix Medical. And now, Therix has managed to spin off a company of its own – Bluegrass Vascular Technologies (BVT), which develops and commercializes devices and methods that improve vascular access procedures.

READ MORE

2011

Bluegrass Vascular focuses on Surfacer ‘inside out’ catheter

November 16, 2011

PUBLICATION: Medical Device Daily

Medical technology incubator Therix Medical (Lexington, Kentucky) reported the launch of spin-out Bluegrass Vascular Technologies, a stand-alone company specializing in life-saving devices and methods that address shortcomings in vascular access procedures. Bluegrass Vascular Technologies’ flagship product is the Surfacer inside-out access catheter system, an instrumentation set that allows physicians to perform a novel “inside-out” approach to gain venous access

READ MORE

Therix Medical Spins Out Bluegrass Vascular Technologies

November 15, 2011

PUBLICATION: Endovascular Today

Therix Medical (Lexington, KY), a medical technology incubator, announced the spin-out of Bluegrass Vascular Technologies, a stand-alone company dedicated to developing and commercializing devices and methods that address shortcomings in vascular access procedures.

READ MORE

Inside-out access: A new method of lead placement for patients with central venous occlusions

June 1, 2011

PUBLICATION: HeartRhythm, Journal of the Heart Rhythm Society, Volume 8, Issue 6, Pages 851-857

Physicians will increasingly encounter patients who require rhythm management devices but have venous obstructions that prevent conventional access. Alternate access options, such as thoracotomy or transiliac approaches, exist but are associated with greater cost and morbidity.

READ MORE